126 related articles for article (PubMed ID: 32404974)
1. Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma.
Reutter K; Sandmann S; Rohde J; Müller S; Wöste M; Khanam T; Michgehl U; Klapper W; Wößmann W; Seggewiß J; Lenz G; Dugas M; Burkhardt B
Leukemia; 2021 Feb; 35(2):639-643. PubMed ID: 32404974
[No Abstract] [Full Text] [Related]
2. Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.
Aukema SM; Theil L; Rohde M; Bauer B; Bradtke J; Burkhardt B; Bonn BR; Claviez A; Gattenlöhner S; Makarova O; Nagel I; Oschlies I; Pott C; Szczepanowski M; Traulsen A; Kluin PM; Klapper W; Siebert R; Murga Penas EM
Br J Haematol; 2015 Sep; 170(6):814-25. PubMed ID: 26104998
[TBL] [Abstract][Full Text] [Related]
3. The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS.
Hüttl KS; Staiger AM; Richter J; Ott MM; Kalmbach S; Klapper W; Biesdorf AS; Trümper L; Rosenwald A; Ziepert M; Horn H; Ott G
Virchows Arch; 2021 Sep; 479(3):575-583. PubMed ID: 33655392
[TBL] [Abstract][Full Text] [Related]
4. Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
Melchardt T; Magnes T; Hufnagl C; Thorner AR; Ducar M; Neureiter D; Tränkenschuh W; Klieser E; Gaggl A; Rösch S; Rasp G; Hartmann TN; Pleyer L; Rinnerthaler G; Weiss L; Greil R; Egle A
Eur J Cancer; 2018 Apr; 93():69-78. PubMed ID: 29477794
[TBL] [Abstract][Full Text] [Related]
5. Extensive Clonal Branching Shapes the Evolutionary History of High-Risk Pediatric Cancers.
Andersson N; Bakker B; Karlsson J; Valind A; Holmquist Mengelbier L; Spierings DCJ; Foijer F; Gisselsson D
Cancer Res; 2020 Apr; 80(7):1512-1523. PubMed ID: 32041836
[TBL] [Abstract][Full Text] [Related]
6. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
[TBL] [Abstract][Full Text] [Related]
7. Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma.
Guo L; Yi X; Chen L; Zhang T; Guo H; Chen Z; Cheng J; Cao Q; Liu H; Hou C; Qi L; Zhu Z; Liu Y; Kong R; Zhang C; Zhou X; Zhang Z; Song T; Xue R; Zhang N
Gastroenterology; 2022 Jan; 162(1):238-252. PubMed ID: 34481846
[TBL] [Abstract][Full Text] [Related]
8. Dynamic change of variant allele frequency reveals disease status, clonal evolution and survival in pediatric relapsed B-cell acute lymphoblastic leukaemia.
Wu S; Liu L; Chu X; Zheng J; Chen Z; Gao L; Xiao P; Lu J; Ji Q; Ling J; Cao S; Pan J; Qin J; Hu S
Clin Transl Med; 2022 May; 12(5):e892. PubMed ID: 35605061
[No Abstract] [Full Text] [Related]
9. Clonal evolution of glioblastoma under therapy.
Wang J; Cazzato E; Ladewig E; Frattini V; Rosenbloom DI; Zairis S; Abate F; Liu Z; Elliott O; Shin YJ; Lee JK; Lee IH; Park WY; Eoli M; Blumberg AJ; Lasorella A; Nam DH; Finocchiaro G; Iavarone A; Rabadan R
Nat Genet; 2016 Jul; 48(7):768-76. PubMed ID: 27270107
[TBL] [Abstract][Full Text] [Related]
10. A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis.
Penther D; Viailly PJ; Latour S; Etancelin P; Bohers E; Vellemans H; Camus V; Menard AL; Coutant S; Lanic H; Lemasle E; Drieux F; Veresezan L; Ruminy P; Raimbault A; Soulier J; Frebourg T; Tilly H; Jardin F
Genes Chromosomes Cancer; 2019 Aug; 58(8):595-601. PubMed ID: 30779244
[TBL] [Abstract][Full Text] [Related]
11. Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia.
Sayyab S; Lundmark A; Larsson M; Ringnér M; Nystedt S; Marincevic-Zuniga Y; Tamm KP; Abrahamsson J; Fogelstrand L; Heyman M; Norén-Nyström U; Lönnerholm G; Harila-Saari A; Berglund EC; Nordlund J; Syvänen AC
Sci Rep; 2021 Aug; 11(1):15988. PubMed ID: 34362951
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum.
Momose S; Weißbach S; Pischimarov J; Nedeva T; Bach E; Rudelius M; Geissinger E; Staiger AM; Ott G; Rosenwald A
Leukemia; 2015 Aug; 29(8):1789-91. PubMed ID: 25673238
[No Abstract] [Full Text] [Related]
13. Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy.
de Roest RH; Mes SW; Poell JB; Brink A; van de Wiel MA; Bloemena E; Thai E; Poli T; Leemans CR; Brakenhoff RH
Clin Cancer Res; 2019 Dec; 25(23):7256-7265. PubMed ID: 31439582
[TBL] [Abstract][Full Text] [Related]
14. A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission.
Kojima M; Nakamura N; Yabe M; Tokunaka M; Kikuti YY; Kikuchi T; Murayama H; Moriuchi M; Tsuboi K; Ogawa Y; Ando K
Int J Hematol; 2015 May; 101(5):520-4. PubMed ID: 25555480
[TBL] [Abstract][Full Text] [Related]
15. Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
Le Bris Y; Magrangeas F; Moreau A; Chiron D; Guérin-Charbonnel C; Theisen O; Pichon O; Canioni D; Burroni B; Maisonneuve H; Thieblemont C; Oberic L; Gyan E; Pellat-Deceunynck C; Hermine O; Delfau-Larue MH; Tessoulin B; Béné MC; Minvielle S; Le Gouill S
Hematol Oncol; 2020 Oct; 38(4):446-455. PubMed ID: 32472610
[TBL] [Abstract][Full Text] [Related]
16. Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Melchardt T; Hufnagl C; Weinstock DM; Kopp N; Neureiter D; Tränkenschuh W; Hackl H; Weiss L; Rinnerthaler G; Hartmann TN; Greil R; Weigert O; Egle A
Oncotarget; 2016 Aug; 7(32):51494-51502. PubMed ID: 27285986
[TBL] [Abstract][Full Text] [Related]
17. The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin.
Ambrosio MR; Piccaluga PP; Ponzoni M; Rocca BJ; Malagnino V; Onorati M; De Falco G; Calbi V; Ogwang M; Naresh KN; Pileri SA; Doglioni C; Leoncini L; Lazzi S
PLoS One; 2012; 7(8):e44315. PubMed ID: 22952953
[TBL] [Abstract][Full Text] [Related]
18. MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma.
Hüllein J; Słabicki M; Rosolowski M; Jethwa A; Habringer S; Tomska K; Kurilov R; Lu J; Scheinost S; Wagener R; Huang Z; Lukas M; Yavorska O; Helfrich H; Scholtysik R; Bonneau K; Tedesco D; Küppers R; Klapper W; Pott C; Stilgenbauer S; Burkhardt B; Löffler M; Trümper LH; Hummel M; Brors B; Zapatka M; Siebert R; Kreuz M; Keller U; Huber W; Zenz T
Cancer Res; 2019 Jun; 79(12):3125-3138. PubMed ID: 31000522
[TBL] [Abstract][Full Text] [Related]
19. Frequency and clinical implications of SOX11 expression in Burkitt lymphoma.
Wästerlid T; Nordström L; Freiburghaus C; Pedersen M; Nørgaard P; Gang AO; Brown P; Dictor M; Jerkeman M; Ek S
Leuk Lymphoma; 2017 Jul; 58(7):1760-1763. PubMed ID: 27869516
[No Abstract] [Full Text] [Related]
20. Longitudinal change of genetic variations in cetuximab-treated metastatic colorectal cancer.
Kim SY; Kim K; Cho SH; Chun SM; Tak E; Hong YS; Kim JE; Kim TW
Cancer Genet; 2021 Nov; 258-259():27-36. PubMed ID: 34315006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
